The economic and social value of spa tourism: The case of balneotherapy in Maresme, Spain.
Journal
PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081
Informations de publication
Date de publication:
2022
2022
Historique:
received:
09
09
2021
accepted:
22
12
2021
entrez:
31
1
2022
pubmed:
1
2
2022
medline:
22
2
2022
Statut:
epublish
Résumé
The aim of this article is to assess both the economic and social value of balneotherapy and spa tourism, being the first paper in carrying out this analysis. The study has been conducted in Maresme, a region of Catalonia, Spain. On the one hand, an Input-Output (IO) model with a Social Accounting Matrix (SAM) has been carried out to assess the economic value. On the other hand, a Cost-Benefit Analysis (CBA) has been used to monetise the social value in this region, taking into account, among other concepts, direct and indirect health profits, given that balneotherapy helps to alleviate various diseases. The results show that whereas the economic multiplier is 1.529 considering the direct and indirect effects and 1.712 taking into account also the induced effects, which are similar to health and medical tourism multipliers, social value generates additional positive value, given that the cost-benefit ratio is 1.858. The theoretical implications of the paper as well as the findings' implications for policy so as to encourage investments in spa tourism are discussed.
Identifiants
pubmed: 35100293
doi: 10.1371/journal.pone.0262428
pii: PONE-D-21-29214
pmc: PMC8803250
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0262428Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
Rheumatology (Oxford). 2006 Jul;45(7):880-4
pubmed: 16449365
Int J Biometeorol. 2020 Jul;64(7):1247-1261
pubmed: 32200439
Front Psychol. 2020 Dec 23;11:632600
pubmed: 33424732
Spine (Phila Pa 1976). 2011 Feb 1;36(3):E213-9
pubmed: 21079541
An Med Interna. 2003 Mar;20(3):111-3
pubmed: 12756894
Eur J Oncol Nurs. 2014 Oct;18(5):505-11
pubmed: 24882370
Arthritis Rheum. 2002 Oct 15;47(5):459-67
pubmed: 12382292
Medicine (Baltimore). 2019 Sep;98(37):e17092
pubmed: 31517832
J Pain Res. 2021 Aug 17;14:2491-2500
pubmed: 34429648
PLoS One. 2010 Sep 29;5(9):
pubmed: 20927377
Int J Biometeorol. 2018 Aug;62(8):1345-1360
pubmed: 29675710
Int J Biometeorol. 2017 Dec;61(12):2159-2173
pubmed: 28849535
Expert Rev Pharmacoecon Outcomes Res. 2006 Aug;6(4):447-54
pubmed: 20528514
Panminerva Med. 2003 Sep;45(3):211-7
pubmed: 14618120
Rheumatology (Oxford). 2007 Sep;46(9):1454-9
pubmed: 17636181
Front Psychol. 2020 Dec 29;11:629951
pubmed: 33447250
Anthropol Med. 2011 Apr;18(1):55-66
pubmed: 21563003
Evid Rep Technol Assess (Summ). 2002 Mar;(47):1-11
pubmed: 11979732
Int J Biometeorol. 2010 Sep;54(5):495-507
pubmed: 20532921
J Nippon Med Sch. 2018;85(4):196-203
pubmed: 30259887
Arthritis Care Res (Hoboken). 2017 Jul;69(7):966-972
pubmed: 27723261
Int J Equity Health. 2013 Jan 05;12:2
pubmed: 23289812
Rev Rhum Engl Ed. 1998 Mar;65(3):173-80
pubmed: 9574474
Front Psychol. 2020 Feb 14;11:77
pubmed: 32116904
Int J Biometeorol. 2018 May;62(5):897-905
pubmed: 29322254
Clin Ter. 2021 Jul 05;172(4):372-387
pubmed: 34247222
Forsch Komplementarmed Klass Naturheilkd. 2005 Aug;12(4):196-201
pubmed: 16137981